Congenital methemoglobinemia type II in a 5‐year‐old boy
Open Access
- 7 December 2017
- journal article
- research article
- Published by Wiley in Clinical Case Reports
- Vol. 6 (1) , 170-178
Abstract
Key Clinical Message: Congenital Methemoglobinemia is a rare neurologic condition which can mimic other diseases such as epilepsy syndromes and leukodystrophies. The responsible gene, CYB5R3 , is not typically included on commonly order neurologic and epilepsy panels. We recommend that laboratories include this gene on these tests which often precede larger‐scale genetic studies.Keywords
This publication has 34 references indexed in Scilit:
- Genetic Mapping and Exome Sequencing Identify Variants Associated with Five Novel DiseasesPLOS ONE, 2012
- Cerebellar atrophy in a child with hereditary methemoglobinemia type IIBrain and Development, 2011
- Severe mental retardation and recessive congenital methemoglobinemia in three Indian patients: Compound heterozygous for NADH‐cytochrome b5 reductase gene mutationsAmerican Journal of Hematology, 2011
- A Novel Mutation in Type II MethemoglobinemiaJournal of Child Neurology, 2009
- Recessive congenital methaemoglobinaemia: cytochrome b5 reductase deficiencyBritish Journal of Haematology, 2008
- Recessive hereditary methaemoglobinaemia, type II: delineation of the clinical spectrumBrain, 2008
- A novel mutation in theDIA1 gene in a patient with methemoglobinemia type IIAmerican Journal of Medical Genetics Part A, 2005
- Severe neurological impairment in hereditary methaemoglobinaemia type 2European Journal of Pediatrics, 2004
- Cloning and chromosomal mapping of human cytochrome b5 reductase (DIA1)Annals of Human Genetics, 1988
- Alteration of NADH-diaphorase and cytochrome b5 reductase activities of erythrocytes, platelets, and leucocytes in hereditary methaemoglobinaemia with and without mental retardation.Journal of Medical Genetics, 1982